BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Refardt J, Imber C, Sailer CO, Jeanloz N, Potasso L, Kutz A, Widmer A, Urwyler SA, Ebrahimi F, Vogt DR, Winzeler B, Christ-Crain M. A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis. J Am Soc Nephrol 2020;31:615-24. [PMID: 32019783 DOI: 10.1681/ASN.2019090944] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lawless SJ, Thompson C, Garrahy A. The management of acute and chronic hyponatraemia. Ther Adv Endocrinol Metab 2022;13:20420188221097343. [PMID: 35586730 DOI: 10.1177/20420188221097343] [Reference Citation Analysis]
2 Lechner K, Schunkert H. [Personalized treatment concepts for arterial hypertension]. Herz 2021;46:91-104. [PMID: 33433651 DOI: 10.1007/s00059-020-05010-1] [Reference Citation Analysis]
3 Kapłon-Cieślicka A, Soloveva A, Mareev Y, Cabac-Pogorevici I, Verbrugge FH, Vardas P. Hyponatraemia in heart failure: time for new solutions? Heart 2021:heartjnl-2021-320277. [PMID: 34903584 DOI: 10.1136/heartjnl-2021-320277] [Reference Citation Analysis]